AU5522498A - Substituted aryl piperazines as modulators of chemokine receptor activity - Google Patents

Substituted aryl piperazines as modulators of chemokine receptor activity

Info

Publication number
AU5522498A
AU5522498A AU55224/98A AU5522498A AU5522498A AU 5522498 A AU5522498 A AU 5522498A AU 55224/98 A AU55224/98 A AU 55224/98A AU 5522498 A AU5522498 A AU 5522498A AU 5522498 A AU5522498 A AU 5522498A
Authority
AU
Australia
Prior art keywords
modulators
substituted aryl
chemokine receptor
receptor activity
aryl piperazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55224/98A
Inventor
Malcolm Maccoss
Sander G. Mills
Martin S. Springer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU5522498A publication Critical patent/AU5522498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55224/98A 1996-12-13 1997-12-12 Substituted aryl piperazines as modulators of chemokine receptor activity Abandoned AU5522498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3288996P 1996-12-13 1996-12-13
US60032889 1996-12-13
US3356796P 1996-12-20 1996-12-20
US60033567 1996-12-20
PCT/US1997/022769 WO1998025617A1 (en) 1996-12-13 1997-12-12 Substituted aryl piperazines as modulators of chemokine receptor activity

Publications (1)

Publication Number Publication Date
AU5522498A true AU5522498A (en) 1998-07-03

Family

ID=26709019

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55224/98A Abandoned AU5522498A (en) 1996-12-13 1997-12-12 Substituted aryl piperazines as modulators of chemokine receptor activity

Country Status (2)

Country Link
AU (1) AU5522498A (en)
WO (1) WO1998025617A1 (en)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US6136827A (en) * 1997-07-25 2000-10-24 Merck & Co., Inc. Cyclic amine modulations of chemokine receptor activity
US6166037A (en) * 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
ID24475A (en) 1997-11-18 2000-07-20 Teijin Limeted Cs AMINIC CYCLICS AND ITS USE AS DRUGS
JP2002501052A (en) 1998-01-21 2002-01-15 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Chemokine receptor antagonists and methods of use thereof
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1999037651A1 (en) 1998-01-21 1999-07-29 Millenium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6140349A (en) 1998-02-02 2000-10-31 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
GB9819860D0 (en) 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
CA2347912A1 (en) 1998-12-18 2000-06-22 Soo S. Ko Heterocyclic piperidines as modulators of chemokine receptor activity
EP1140833A1 (en) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
IL142768A0 (en) 1998-12-18 2002-03-10 Du Pont Pharm Co N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6492400B1 (en) 1998-12-18 2002-12-10 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ATE302606T1 (en) 1998-12-18 2005-09-15 Bristol Myers Squibb Pharma Co N-UREIDOALKYLPIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
EP1013276A1 (en) 1998-12-23 2000-06-28 Pfizer Inc. Aminoazacycloalkanes as CCR5 modulators
PE20001420A1 (en) * 1998-12-23 2000-12-18 Pfizer CCR5 MODULATORS
JP2002538151A (en) 1999-03-02 2002-11-12 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド Compounds useful as reversible inhibitors of cathepsin
EP1156801B1 (en) * 1999-03-10 2004-07-07 Smithkline Beecham Corporation SUBSTITUTED BENZO(1,2-b:5,4-b')DIPYRAN-4-AMINES AS CCR5 MODULATORS
GB9907571D0 (en) 1999-04-06 1999-05-26 Zeneca Ltd Compounds
HUP0202734A3 (en) * 1999-05-04 2003-11-28 Schering Corp Use of pegylated interfron alfa-ccr5 antagonist combination for hiv therapy
US6635646B1 (en) 1999-05-04 2003-10-21 Schering Corporation Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
EP1050307A1 (en) * 1999-05-06 2000-11-08 Applied Research Systems ARS Holding N.V. CCR4 antagonists in sepsis
WO2000069815A1 (en) * 1999-05-13 2000-11-23 Teijin Limited Ureido-substituted cyclic amine derivatives and their use as drug
DK1179341T3 (en) 1999-05-18 2006-03-27 Teijin Ltd Medicines or preventive agents for diseases associated with chemokines
AU5469400A (en) 1999-06-11 2001-01-02 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
US6358979B1 (en) 1999-06-11 2002-03-19 Merck & Co., Inc. N-cyclopentyl modulators of chemokine receptor activity
WO2000076514A1 (en) 1999-06-11 2000-12-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
ES2274793T3 (en) * 1999-06-11 2007-06-01 MERCK & CO., INC. N-CYCLOPENTILIC MODULARS OF THE ACTIVITY OF THE CHEMIOQUINE RECEPTOR.
US6500844B1 (en) 1999-06-11 2002-12-31 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
AU5473800A (en) 1999-06-11 2001-01-02 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
AU5328500A (en) 1999-06-11 2001-01-02 Merck & Co., Inc. N-cyclopentyl modulators of chemokine receptor activity
EP1201239A4 (en) 1999-08-04 2004-12-08 Teijin Ltd Cyclic amine ccr3 antagonists
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
SE9903544D0 (en) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
US6897234B2 (en) 1999-12-17 2005-05-24 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
GB2359081A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
ATE255584T1 (en) * 2000-02-11 2003-12-15 Astrazeneca Ab PYRIMIDINE COMPOUNDS AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
GB2359078A (en) * 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
US6410566B1 (en) 2000-05-16 2002-06-25 Teijin Limited Cyclic amine derivatives and their use as drugs
SI1284974T1 (en) * 2000-05-26 2004-08-31 Pfizer Inc. Triazolyl tropane derivatives as ccr5 modulators
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
BR0111878A (en) 2000-06-30 2005-05-24 Bristol Myers Squibb Co N-ureido- (heterocycloalkyl) piperidines as modulators of chemokine receptor activity
SE0003828D0 (en) 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
SE0101322D0 (en) 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
CA2445348A1 (en) 2001-04-27 2002-11-07 Mitsubishi Pharma Corporation Novel benzylpiperidine compound
US6974869B2 (en) 2001-09-18 2005-12-13 Bristol-Myers Squibb Pharma Company Piperizinones as modulators of chemokine receptor activity
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
JP4723242B2 (en) 2002-06-12 2011-07-13 ケモセントリックス インコーポレーティッド 1-Aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
US7842693B2 (en) 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
WO2004041210A2 (en) 2002-11-05 2004-05-21 Smithkline Beecham Corporation Antibacterial agents
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
JPWO2004092136A1 (en) * 2003-04-18 2006-07-06 小野薬品工業株式会社 Nitrogen-containing heterocyclic compounds and uses thereof
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
WO2005061463A1 (en) 2003-12-23 2005-07-07 Astex Therapeutics Limited Pyrazole derivatives as protein kinase modulators
CA2558211C (en) 2004-03-03 2013-09-03 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7435831B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
ES2353309T3 (en) 2004-03-08 2011-03-01 Prosidion Ltd. HYDRAZIDS OF THE PIRROLOPIRIDIN-2-CARBOXYL ACID AS INHIBITORS OF GLUCOGEN PHOSPHORILASE.
EP1723178A4 (en) 2004-03-12 2007-12-12 Human Genome Sciences Inc Human g-protein chemokine receptor (ccr5) hdgnr10
PL1801108T3 (en) 2004-09-08 2013-04-30 Mitsubishi Tanabe Pharma Corp Morpholine compounds for the treatment of inflammations
US20090099176A1 (en) 2004-12-02 2009-04-16 Thomas Martin Krulle Pyrrolopyridine-2-carboxylic acid amides
US8343953B2 (en) 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
JP5345842B2 (en) 2005-06-23 2013-11-20 アステックス・セラピューティクス・リミテッド Pharmaceutical combinations containing pyrazole derivatives as protein kinase modulators
GB0704932D0 (en) 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
BR112012024522A2 (en) 2010-04-02 2017-08-08 Phivco 1 Llc combination, use of a combination, pharmaceutical composition, single dosage form, kit, and method for treating a disorder
GB201017345D0 (en) 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
SG11201707429VA (en) 2015-04-02 2017-10-30 Proximagen Ltd Novel therapies for cancer
CN106117242B (en) * 2016-06-27 2018-08-03 山东大学 Tetrahydric thiapyran miazines derivative and the preparation method and application thereof
WO2018106959A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3554541B1 (en) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
EP3749324A4 (en) * 2017-12-28 2022-03-09 Reviva Pharmaceuticals Inc. Methods for treating pulmonary fibrosis
KR20210095165A (en) 2018-11-19 2021-07-30 프로제너티, 인크. Methods and devices for treating diseases with biopharmaceuticals
EP4309722A2 (en) 2019-12-13 2024-01-24 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231082A (en) * 1976-09-17 1977-03-09 Ajinomoto Co Inc Preparation of 2- piperazinophenylpropionic acid
JPS56150068A (en) * 1980-04-23 1981-11-20 Nisshin Flour Milling Co Ltd Nonaprenylamine derivative
FR2482101A1 (en) * 1980-05-07 1981-11-13 Cerm Cent Europ Rech Mauvernay 2-METHANOL A-AMINOMETHYL BENZO (1,4) DIOXINS, PROCESS FOR PREPARING THEM AND THEIR THERAPEUTIC APPLICATION
HUT41752A (en) * 1984-11-30 1987-05-28 Sandoz Ag Process for producing piperazine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1998025617A1 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
AU5522498A (en) Substituted aryl piperazines as modulators of chemokine receptor activity
AU5812498A (en) Substituted aminoquinolines as modulators of chemokine receptor activity
AU2482100A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU3126700A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2057200A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2056700A (en) 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
AU2056800A (en) Heterocyclic piperidines as modulators of chemokine receptor activity
AU4074200A (en) Pyrrolidine modulators of chemokine receptor activity
AU5803398A (en) Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5604998A (en) Spiro-substituted azacycles as modulators of chemokine receptor activity
AU4201200A (en) Pyrrolidine modulators of chemokine receptor activity
EP1171122A4 (en) Pyrrolidine modulators of chemokine receptor activity
EP1003743A4 (en) 3,3-disubstituted piperidines as modulators of chemokine receptor activity
AU5600100A (en) Cyclopentyl modulators of chemokine receptor activity
EP1003514A4 (en) Cyclic amine modulators of chemokine receptor activity
EP1173170A4 (en) Pyrrolidine modulators of chemokine receptor activity
AU3927493A (en) Improved enzyme electrodes
AU1529997A (en) Substituted histidine inhibitors of protein farnesyltransferase
AU3386400A (en) 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
AU3386500A (en) 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) Pyrrolidine modulators of chemokine receptor activity
AU1201401A (en) Benzylcycloalkyl amines as modulators of chemokine receptor activity
AU7592998A (en) Modulators of tissue regeneration
HU9702242D0 (en) Inozitol-glykanes of inzulin-like activity
AU4989397A (en) Seismic activity predictor